Internal Medicine · Chester, VA
NPI
1134198187
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1714 E Hundred Rd, Suite 101
Chester, VA, 23836
Phone (804) 530-5293
Groups this clinician bills Medicare through
Medicare paid, 2024
$312K
3,542 services
Medicare patients, 2024
647
Average age 75
Drug cost, 2024
$1.3M
15,959 prescriptions
Company payments, 2024
$117
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gohar M Abbasi was code 99309 (snf e&m), 1,704 times for 284 patients. In total Gohar M Abbasi billed 3,542 services in 22 codes, and Medicare paid $312K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Office | 1,704 | 284 | $81.16 | $138K |
| 99214 Office E&M - Established | Office | 609 | 192 | $87.64 | $53K |
| 99310 SNF E&M | Office | 445 | 180 | $116.95 | $52K |
| 99349 Home E&M - New and Established | Office | 233 | 61 | $86.07 | $20K |
| 99213 Office E&M - Established | Office | 192 | 112 | $54.35 | $10K |
| 99306 SNF E&M | Office | 179 | 170 | $137.08 | $25K |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 41 | 35 | $41.43 | $1,699 |
| 99316 SNF E&M | Office | 29 | 29 | $97.40 | $2,825 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 20 | 20 | $125.98 | $2,520 |
| 99305 SNF E&M | Office | 16 | 16 | $96.36 | $1,542 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 15 | 12 | $32.46 | $487 |
| 99345 Home E&M - New and Established | Office | 11 | 11 | $141.18 | $1,553 |
| 99205 Office E&M - New | Office | 11 | 11 | $154.63 | $1,701 |
By year: 2022 $337K for 4,403 services; 2023 $332K for 3,926 services; 2024 $312K for 3,542 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gohar M Abbasi prescribed most often to Medicare patients was Atorvastatin Calcium, with 849 prescriptions and refills. In total Gohar M Abbasi wrote 15,959 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 849 | 1,202 | 192 | $11K |
| Amlodipine Besylate Generic | 709 | 1,138 | 182 | $5,119 |
| Trazodone Hcl Generic | 378 | 395 | 74 | $3,476 |
| Levothyroxine Sodium Generic | 374 | 500 | 76 | $4,411 |
| Eliquis Apixaban | 348 | 359 | 57 | $126K |
| Sertraline Hcl Generic | 343 | 374 | 69 | $3,419 |
| Lisinopril Generic | 335 | 503 | 72 | $2,262 |
| Pantoprazole Sodium Generic | 328 | 415 | 84 | $7,034 |
| Gabapentin Generic | 295 | 337 | 87 | $3,818 |
| Furosemide Generic | 292 | 370 | 71 | $1,884 |
| Metformin Hcl Generic | 287 | 512 | 70 | $1,895 |
| Tamsulosin Hcl Generic | 285 | 357 | 63 | $5,068 |
| Omeprazole Generic | 284 | 479 | 83 | $3,439 |
| Metoprolol Succinate Generic | 237 | 374 | 63 | $3,699 |
| Losartan Potassium Generic | 230 | 345 | 56 | $2,332 |
Brand drugs: 2,329 claims; generic drugs: 13,451 claims; opioid claims: 246.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Gohar M Abbasi $117 ($117 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $117.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $117 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.